"The domestic vaccine differs from others in that the temperature regime is maintained from two to +8 degrees, which is particularly acceptable for logistical purposes. This vaccine is inactivated, developed by Kazakh scientists, " Deputy head of the regional health Department Arman Dzhansengirov said during the receipt of the vaccine batch.
For reference:
The first 50 thousand doses of the QazVac vaccine will be distributed to the SK-Pharmacy hubs and then delivered to the warehouses of the health departments of all regions of the country. On April 26 this year, the population will be vaccinated with the "QazVac" vaccine. In May, it is planned to release the next batch in the amount of 50 thousand doses. Further, the production of the vaccine will be gradually increased to 500-600 thousand doses per month.

The domestic vaccine is included in the register of the World Health Organization. Its complete safety has been proven, and the vaccine forms a strong immunity against coronavirus infection. The advantage of an inactivated vaccine is that it does not cause vaccine-associated diseases. In addition, the methods of delivery of the "QazVac" vaccine do not require complex refrigeration systems, they are transported in a refrigerator at a temperature of + 2-8 degrees.